Arctech Solar Unveils New Website to Boost Branding Efforts

SHANGHAI, Oct. 9, 2020 /PRNewswire/ — Arctech Solar, a leading solar tracking, racking and BIPV system provider, is proud to announce the launch of its newly redesigned website, aiming to offer an elevated and user-friendly browsing experience for our trusted and valued customers and business partners.

This is a new milestone in the innovation-driven, customer-centered company’s branding efforts. Arctech Solar’s new website features improved navigation and functionality, it treats orange as the main background color which is simple and graceful. More importantly, Arctech Solar endeavors to provide its current and prospective customers and partners with the most accurate, up-to-date information on the full product portfolio and comprehensive services of smart solar trackers that it can offer. A generous application of videos, photos and graphics, along with sufficiently detailed and engaging content regarding the company’s products, solutions, and cases to guide visitors. Amongst the new features, the site contains integrated social media buttons for LinkedIn, Facebook, Twitter, YouTube and WeChat to foster improved communication with partners and clients.

Arctech Solar is showing strong momentum in growth and innovation this year despite Covid-19 disruption. It successfully went public on Shanghai Sci-tech Innovation Board in August, and has officially unveiled state-of-the-art SkySmart II solution, which is compatible with high-power & large modules, and satisfy the stability and LCOE requirement. The newly-launched website is also a new starting point for the company. Looking forward, Arctech Solar is excited to see opportunity abounding, and will stay committed to serving valued customers and partners with top-quality products and excellent services.

For more information on Arctech Solar and to view the new site, please visit www.arctechsolar.com starting September 2020.

About Arctech Solar

Arctech Solar (SSE-STAR: 688408) is one of the world’s leading manufacturers and solution providers of solar tracking, racking and BIPV systems. In

Silicon Therapeutics Unveils Refreshed Corporate Branding and Redesigned Website

Silicon Therapeutics, a privately-held, fully integrated drug design, discovery and development company focused on small molecule therapeutics, today introduced an updated corporate website, which reflects the company’s mission, research approach and core values.

The new Silicon Therapeutics site more accurately tells the company’s story and clearly highlights the company’s mission to improve the lives of patients by creating novel, disease-modifying medicines for challenging targets, using its proprietary, quantum physics-driven discovery engine.

“We worked to develop a meaningful brand architecture and visual identity that embodies the company’s strategic approach and core ethos,” said Lanny Sun, co-founder and chief executive officer. “This project has been part of our strategy to more fully engage with investors, potential partners, scientists and future employees while highlighting our differentiated approach and the opportunities that our platform presents for the company.”

The new site is expanded with deeper scientific content and the layout is structured for ease of navigation to provide a seamless user experience.

“While the new brand identity gives Silicon Therapeutics a bright and sophisticated look with distinctive graphics and other visuals, this update was not just cosmetic,” said Woody Sherman, Ph.D., chief scientific officer, who led the initiative. “Visitors to our website can efficiently learn about our proprietary computational physics platform, explore our pipeline, understand our research focus and gain a glimpse into our unique culture.”

The Silicon Therapeutics platform enables the company to perform accurate, atomic-level, quantum physics-based simulations fast enough and at the scale necessary to reveal essential drug design insights and break through the bottlenecks preventing effective discovery of therapeutics for biologically validated but chemically intractable targets. The platform is cohesively integrated with a world-class wet lab including biophysics, chemistry and biology, enabling rapid hypothesis-driven data generation to advance drug discovery projects on targets that have traditionally been considered undruggable.